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INTRODUCTION 
Menstrual irregularity is one of the 
commonest gynaecological complaints seen in 
the age group of 12-45yrs. One of the causes for 
this irregularity is said to be polycystic ovarian 
disease. The incidence varies from 5-15%. It can 
be considered as a multifactorial disorder 
characterised by amenorrhoea or 
oligomenorrhoea, delayed and irregular periods, 
hirsutism, hoarseness of voice, obesity etc[1]. 
Diagnosis is confirmed by ultra sonography 
examination and hormonal assay.[2] This 
complex disorder is characterized by excessive 
androgen production leading to increased LH 
(Luteinising Hormone) hormone associated with 
raised insulin and decreased FSH (Follicle 
stimulating hormone). Even the SHBG (Sex 
Hormone Binding Globulin) appears to be 
reduced. Due to above mentioned causes the 
follicular growth is hampered which contributes 
towards anovulation, oligomenorrhoea, or 
hypomenorrhoea.[3] In Ayurveda though exact 
correlation cannot be made, it can be better 
explained under Rasa Nimittaja vyadhi [4] with 
involvement of Medho Dhatu, Vata and Kapha 
doshas. Keeping all this in mind Madhutailika 
basti was selected for 8 days duration and 
Shamanaushadhis like Navaka Guggulu, Arogya 
vardhini vati and Asanabilwadi kwatha was later 
advised for a period of three months.  
MATERIAL AND METHODS 
The present study is an observational 
study with open label study design. All subjects 
were administered Madhutailika basti for a 
period of 8 days. Later they were given shaman 
Aoushadis like Navaka Guggulu, Arogyavardhini 
vati, and Asanabilwadi kwatha for a period of 
three months. Madhutailika yoga basti is 
Polycystic ovarian disease (PCOD) is emerging as a main cause of menstrual irregularities, 
mainly observed in age group of 12-45 yrs of age. Based on present data available, 5-15% of 
females suffer from this condition that includes symptoms like obesity, irregular menstrual 
cycle, hirsutism etc. In Ayurveda though exact correlation cannot be ascertained, it can be 
better explained under Rasa nimittaja vyadhi, where the involvement of Medo dhatu, Vata 
and Kapha doshas are seen. Madhutailika basti which carries numerous positive clinical 
results as per the classical reference based on the various pharmacological properties on 
Medo dhatu dustigata vyadhis, because of its ingredients. Based on the available references, 
Madhutailika basti along with other Shaman ausudhis are taken for a pilot observational 
study at Shri Kalabyraveshwaraswamy Ayurvedic Medical College Hospital & Research 
Centre Vijayanagar Bangalore. Post approval of the institution ethical committee, 
Madhutailika basti was administered to selected patients for a period of 8 days followed by 
administration of Shaman aushadis for a period of next 3-months. The overall results 
showed marked improvement in 70%, moderate improvement in 20% of the patients. All 
patients completed the study successfully without any drop outs.  
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prepared as per the description in Charaka 
samhita siddisthan. Other formulated products 
purchased from the approved pharmacy stores 
manufactured by approved pharmaceutical 
manufacturers. For example: Navaka Guggulu 
manufactured by Amrita Pharmacy Hyderabad, 
Arogyavardhini vati by Dhootapapeshwara 
Mumbai, and Asanabilwadi kwatha 
manufactured by Shri Dharmasthala 
Manjunatheshwara Ayurvedic Pharmacy Hassan.  
Subjective Parameter  
• Irregular menstruation  
• Body weight  
Objective Parameter 
The following parameters are considered as 
objective parameter.  
• USG revealing polycystic ovaries 
• Hormonal assay 
Assessment criteria 
• Regularisation of the menstrual cycle.  
• Change in body weight.  
• Ovulation or changes in the size and 
number of follicles in the ovary.  
• Normalisation of hormone level LH, FSH, 
Testosterone, Fasting insulin SHBG.  
Parameter with gradation Score 
Irregular menstruation 
0 - 28-32 days menstrual cycle 
1 - 33-38 days menstrual cycle 
2 - 39-44 days menstrual cycle 
3 - above 45 days menstrual cycle 
Body weight 
0 - no change 
1 - Reduced 1 to 1. 5 kgs 
2 - Reduced 1. 6 to 2 kgs 
3 - Reduced 2. 1 to 2.5 kgs 
Impact on cyst 
5 - Reduction in cyst 10% 
4 - Reduction in 20% 
3 - Reduction in 40% 
2 - Reduction in 60% 
1 - Reduction in more than 80% 
Impact on LH Hormone 
5 - No change 
4 - Change in 25% 
3 - Change in 50% 
  2 - Change in 75% 
  1 - Change in more than 75% 
Impact on Testosterone  
 5 - No change 
 4 - Change in 25% 
 3 - Change in 50% 
 2 - Change in 75% 
 1 - Change in more than 75% 
Impact on serum fasting insulin 
5 - No change 
4 - Change in 25% 
3 - Change in 50% 
2 - Change in 75% 
1 -Change in more than 75% 
Objective parameters were assessed before 
treatment and after treatment and the results 
were assessed using mean value.  
Sample Size and Method 
• Sample size: 10 without any drop outs.  
• Study design : Open level clinical trial  
• Number of groups : Single group 
Drug schedule and Dosage [5,6,7] 
• Madhutailika yoga basti.  
• Shamana aushadi: 
The following formulations are considered as 
Shaman aushadis for this specific study.  
• Navaka Guggulu - 2 tab BID internally 
before food along with hot water for three 
months 
• Arogyavardhini vati - 2 tablets BID 
internally after food along with hot water 
for three months.  
• Asanabilwadi kwatha - 20ml BID internally 
before food along with equal quantity of 
water for three months.  
Duration of Treatment: 8 days Madhutailika 
basti followed by three months of Shaman 
aushadis.  
Follow up: Once in a month, i.e. at the end of 1st, 
2nd and 3rd months.  
Investigations: USG of pelvic cavity, Hormonal 
assay (LH, FSH, Testosterone, Fasting insulin) 
The volunteers for this study enrolled 
between 01/10/13 to 01/01/14 from the 
OPD/IPD of department of Prasuti tantra-evam-
Stree Roga of SKAMCH & RC, Vijayanagar, 
Bangalore based on the designed protocol which 
has been approved by the institutional ethical 
committee. The inclusion and exclusion criteria 
are followed as per the guidelines and 
specification provided by Dr. D C Dutta and Dr 
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Dewhurt’s Text book of O & G which is based on 
the standard accepted guidelines. The volunteers 
are recruited for the study based on strict follow 
up of inclusion and exclusion criteria, adhesion 
to the guidelines of CRF and follow up protocol 
as mentioned in the table No. 1 
Table 1: Inclusion and Exclusion Criteria 
Inclusion Criteria Exclusion Criteria 
With H/O Irregular menstruation for at least 
previous three cycles with increased body 
weight.  
PCOD associated with any other known or detected 
genital tract abnormalities including Cx.  
Existence of cystic ovary (ies) confirmed by 
USG not old than 3 months before the date of 
reporting  
PCOD with long term unexplained Menorrhagia / 
Metrorrhagia 
Lab report (not old than 3 months) with 
evidence of elevated serum:-LH, fasting 
insulin, & Testosterone.  
Patients Suffering with any other systemic illness 
like chronic liver & kidney failure, heart failure, 
hepatic insufficiency, allergic to the ingredients 
used in this formulation, and pace maker.  
OBSERVATION AND RESULTS 
Out of the (n=10) patients, complaining of irregular menstrual cycle, who diligently followed the 
prescription the mean value of 2.2 before treatment was reduced to1.1 post treatment.  
Table no. 1 Statistical analysis on relief of Irregular menstruation (n=10) 
NO  Mean (BT) Mean (AT) D  SD  SE  T  P  
10  2.2  1.1  1.1  0.74  0.25  4.472  <0.01  
Impact in the Cyst 
Out of the (n=10) patients, complaining of polycystic ovaries, who diligently followed the prescription 
the mean value of 2. 5 before treatment was reduced to 0.5 post treatment.  
Table 2: Statistical analysis on Cyst reduction (n=10) 
NO  Mean (BT) Mean (AT) D  SD  SE  T  P 
10  2.5  0.5  2  0.82  0.27  7.348  <0.001  
Impact in Body Weight 
Out of the (n=10) patients, complaining of increased body weight, who diligently followed the 
prescription the mean value of 2.27 before treatment was reduced to 2.50 post treatment.  
Table 3: Statistical analysis on reduction of Body weight (n=10) 
NO  Mean (BT) Mean (AT) D  SD  SE  T  P  
10  2.27  2.50  1.1  0.74  0.25  4.472  <0.01  
Impact on LH 
Out of the (n=10) patients, complaining of increased LH hormone, who diligently followed the 
prescription the mean value of 14.43 before treatment was reduced to 12.33 post treatment.  
Table 4: Statistical analysis on LH levels (n=10) 
 NO  Mean (BT) Mean (AT) D  SD  SE  T  P  
10  14.43  12.33  2.101  3.47  1.16  1.814  <0.1  
Impact in the Testosterone 
Out of the (n=10) patients, complaining of increased testosterone, who diligently followed the 
prescription the mean value of 2.5 before treatment was reduced to 0.5 post treatment.  
Table 5: Statistical analysis on Testosterone levels (n=10) 
NO  Mean (BT) Mean (AT) D  SD  SE  T  P  
10  4.98  4.367  0.613  0.73  0.23  2.505  <0.5  
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Impact in the Fasting Insulin 
Out of the (n=10) patients, complaining of increased fasting insulin, who diligently followed the 
prescription the mean value of 32.542 before treatment was reduced to 26.976 post treatment.  
Table 5: Statistical analysis on Serum Fasting Insulin levels (n=10) 
NO  Mean (BT) Mean (AT) D  SD  SE  T  P  
10  32.542  26.976   5.566  5.80  1.93  2.880  <0.01  
The overall results were analysed based on the 
following criteria: 
• Pregnancy occurred during or after the 
treatment.  
• Normalization of Hormonal level 
• Regularization of cycle post treatment. 
Present study was carried out to evaluate 
efficacy of Madhutailika Basti and Shaman 
aoushadis in Poly cystic ovarian disease. The 
overall results showed marked improvement 
in 70%, moderate improvement in 20% and 
improvement in 10% of the patients. Highly 
significant results were achieved in 
menstrual irregularity, polycystic ovaries, 
body weight, fasting insulin, testosterone, 
and significant results were achieved with 
regard to level of LH Hormone.  
DISCUSSION 
Present study is carried out to evaluate 
the effect of Madhutailika basti and Shamana 
aushadhis in PCOD (Poly cystic ovarian disease). 
It is a multifactorial disease with manifestation 
of many symptoms like acne, hirsutism, obesity, 
irregular menstrual cycle, and anovulation.[11] 
Though exact pathophysiology of PCOD is not 
understood following can be the causes:  
• Hypothalamic-pituitary compartment 
abnormality, where an increased pulse 
frequency of GnRH leads to increased pulse 
frequency of LH.[12] 
• Androgen excess, here abnormal regulation 
of the androgen forming enzyme (P450 
C17) is main cause for excess production of 
androgen from ovaries.[13]  
• Obesity is associated with reduced SHGB 
(Sex hormone binding globuline). It also 
induces insulin resistance leading to 
hyperinsulinaemia which in turn increases 
the gonadal androgen production.[14] These 
factors hamper the development of follicles, 
leading to anovulatory cycle associated with 
prolonged period of amenorrhoea.  
In Ayurveda, it can be better explained 
under Rasanimittaja vyadhi, with involvement of 
Medho dhatu, Vata & Kapha doshas. Acharya 
Sushruta has mentioned that Rasadhatu is the 
main cause for Stoulya, Prameha, and Karshya 
etc. Due to excessive intake of guru, Snigdha, 
Madhura, Sheeta abhishyandi aharas it leads to 
Agnimandya which further leads to Kapha vriddi 
and Medho dhatu vriddi. This contributes to 
Shrotodusti and Avarana of Rasadhatu by 
Medhodhatu which can cause symptoms like 
stoulya. Artava is also affected because Artava is 
Upadhatu of Rasa dhatu. This produces 
symptoms like Alpartava, Artavakshaya or 
Anartava which can be seen in PCOD. To correct 
the Avarana as well as Vata kapha doshas, and 
Medho dhatu dusti Madhutailika Basti was 
selected, which contains equal quantity of Madhu 
and Taila, Saindhavalavana, Shatapushpa, 
Shatavari erandamoola kwatha. Madhu is having 
Lekhana guna which helps to reduce both Kapha 
and Meda.[15] Tila taila is having Artava jananaka 
property and Erandamoola kwatha acts as 
vatahara.[16] Guggulu having Lekhana and 
Rasayana gunas which helps in reduction of 
increased Medho dhatu and Kapha dosha. Among 
them all are having the karmas like Deepana, 
Pachana, Srotoshodaka, and Medhokaphahara, 
which helps to improve the Jatharagni, 
Dhatwagni as well as Rasadhatu. This intern 
reduces Sthoulya and regularizes the ovulation.  
CONCLUSION 
PCOD is one of the commonest problems 
seen in women today. Most of the times, it 
manifests as oligomenorrhoea or amenorrhoea 
or delayed and irregular periods along with 
hirsutism, hoarseness of voice, obesity etc. Based 
on the properties like Medhokaphahara and 
Vatahara, Deepana, Pachana, and Srotoshodhaka, 
Madhutailika Basti, Navaka Guggulu, 
Arogyavardhini vati, Asanabilwadi kwatha are 
selected for the study. The overall results 
showed marked improvement in 70%, moderate 
improvement in 20% and improvement in 10% 
of the patients. On statistical analysis, efficacy of 
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the trial drugs was found to be highly significant 
in relieving PCOD (P<0.001).  
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Graph I: Relief in Irregular menstruation           Graph II: Relief in the size of polycystic ovaries 
 
        
    Graph III: Reduction of Body weight     Graph IV: hormone level LH 
  
 
          Graph V: Testosterone hormone levels 
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